Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Quickcomparison

Dose Range MK-677 (Ibutamoren) 10–25 mg Ipamorelin 100–300 mcg Frequency Once daily Multiple times daily Administration Oral (capsule or liquid) Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trial

This comparison does not assign a generated winner or score.

  • Dose Range
  • MK-677 (Ibutamoren)
  • 10–25 mg
  • Ipamorelin
  • 100–300 mcg
  • Frequency
  • Once daily
  • Multiple times daily
  • Administration
  • Oral (capsule or liquid)
  • Subcutaneous injection
  • Cycle Length
  • 8-12 weeks
  • Onset Speed
  • Moderate (1-2 weeks)
  • Evidence Level
  • Moderate human trials (Phase 1-2)
  • Efficacy
More references

Related material